News �鶹��ý from University of New Mexico Comprehensive Cancer Center

The Breadth of Breast Cell Types

University of New Mexico Comprehensive Cancer Center — Thu, 31 Oct 2024 13:30:57 EST

October is Breast Cancer Awareness Month, and fittingly, University of New Mexico Comprehensive Cancer Center biologist Curt Hines, PhD, has published a pair of papers that comprehensively describe the twelve major types of cells in the human breast.

The University of New Mexico Comprehensive Cancer Center Receives Three-Year Reaccreditation from the Commission on Cancer

University of New Mexico Comprehensive Cancer Center — Thu, 31 Oct 2024 13:30:24 EST

The University of New Mexico Comprehensive Cancer Center has successfully received reaccreditation from the Commission on Cancer (CoC), a quality program of the American College of Surgeons. The ACS CoC is a consortium of professional organizations dedicated to improving survival and quality of life for patients with cancer by setting and raising standards.

Route 66 SPORE Grant to Study Uterine Cancers

University of New Mexico Comprehensive Cancer Center — Mon, 30 Sep 2024 08:00:16 EST

Kimberly Leslie, MD, at The University of New Mexico Comprehensive Cancer Center, leads the UNM portion of the Route 66 Specialized Program of Research Excellence (SPORE) grant. The grant aims to improve uterine cancer survival. The work is a collaboration between scientists at UNM Comprehensive Cancer Center, Siteman Cancer Center at Washington University in St. Louis, and Stephenson Cancer Center at University of Oklahoma. All three universities lie along Route 66, giving the grant its name.

Amos Joins UNM Cancer Center

University of New Mexico Comprehensive Cancer Center — Tue, 03 Sep 2024 12:05:54 EST

Christopher Amos, PhD, will join The University of New Mexico Comprehensive Cancer Center on October 1, Yolanda Sanchez, PhD, announced. Sanchez leads the UNM Comprehensive Cancer Center as Director and CEO. Amos will serve as Associate Director for Population Sciences and Cancer Control at the UNM Cancer Center and will also serve as Director of the UNM Health Sciences Center (HSC) Data Science Initiative.

UNM Cancer Center Opens Ovarian Cancer Clinical Trial Using HIPEC Surgery

University of New Mexico Comprehensive Cancer Center — Mon, 26 Aug 2024 11:15:50 EST

The University of New Mexico Comprehensive Cancer Center has opened a clinical trial that applies hyperthermic intraperitoneal chemotherapy (HIPEC) -- a proven surgical technique that is used in digestive system cancers -- to ovarian cancer.

UNM Cancer Center Opens Ovarian Cancer Clinical Trial Using HIPEC Surgery

University of New Mexico Comprehensive Cancer Center — Mon, 26 Aug 2024 08:00:00 EST

Promise and Perils of Primary HPV Testing

University of New Mexico Comprehensive Cancer Center — Fri, 02 Aug 2024 16:05:07 EST

Lifestyle Behaviors and Needs After Breast Cancer Diagnosis: A Qualitative Assessment

University of New Mexico Comprehensive Cancer Center — Tue, 23 Jul 2024 12:05:37 EST

G protein-coupled estrogen receptor agonist G-1 decreases ADAM10 levels and NLRP3-inflammasome component activation in response to Staphylococcus aureus alpha-hemolysin

University of New Mexico Comprehensive Cancer Center — Mon, 22 Jul 2024 16:05:03 EST

Travel Distance Does Not Affect Overall Survival in Patients with Appendiceal Adenocarcinoma Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

University of New Mexico Comprehensive Cancer Center — Mon, 22 Jul 2024 15:05:32 EST

Early menopause and hormone therapy as determinants for lung health outcomes: a secondary analysis using the PLCO trial

University of New Mexico Comprehensive Cancer Center — Thu, 18 Jul 2024 17:05:26 EST

Early natural menopause (early-M; <45 years of age) increases the risk of lung morbidities and mortalities in smokers. However, it is largely unknown whether early-M due to surgery demonstrates similar effects and whether menopausal hormone therapy (MHT) is protective against lung diseases.

Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms

University of New Mexico Comprehensive Cancer Center — Thu, 18 Jul 2024 16:05:08 EST

In 2022, Alaggio and colleagues revised the WHO Classification of Haematolymphoid Tumors resulting in elimination of the provisional diagnostic categories of Hairy Cell Leukemia Variant (HCLv) and B Prolymphocytic Leukemia.

Excellence in Radiation Oncology

University of New Mexico Comprehensive Cancer Center — Thu, 11 Jul 2024 16:05:24 EST

The University of New Mexico Comprehensive Cancer Cancer Center achieves accreditation for radiation oncology services from the American Society for Radiation Oncology APEx - Accreditation Program for Excellence

Living Drugs that Fight Cancer

University of New Mexico Comprehensive Cancer Center — Mon, 24 Jun 2024 11:05:09 EST

In Greek mythology, a Chimera is a creature of change, a being possessing the forms of lion, goat and dragon. But unlike the mythical creature, a new approach to fighting cancer cells throughout the body is very real and has arrived at The University of New Mexico Comprehensive Cancer Center.

Gathering STEAM

University of New Mexico Comprehensive Cancer Center — Wed, 12 Jun 2024 11:05:48 EST

The UNM Comprehensive Cancer Center is partnering with Northern Arizona University, New Mexico State University and the Burrell College of Osteopathic Medicine, which is located on NMSU's campus in Las Cruces, to connect emerging cancer disparities researchers with mentors to continue developing these scholars.

Stepping Up Summer Fun: the Cancer Research - Scholarship and Training Experience in Population Sciences (C‐STEPS) Program

University of New Mexico Comprehensive Cancer Center — Mon, 03 Jun 2024 19:05:03 EST

Over the last two decades, strides in cancer prevention, earlier detection, and novel treatments have reduced overall cancer mortality; however, cancer health disparities (CHD) persist among demographically diverse and intersecting populations.

The Role of Transcription Factor IIH Complex in Nucleotide Excision Repair

University of New Mexico Comprehensive Cancer Center — Mon, 13 May 2024 14:05:55 EST

Participatory Action Research to Develop and Implement Multicomponent, Multilevel Strategies for Implementing Colorectal Cancer Screening Interventions in American Indian Communities in New Mexico

University of New Mexico Comprehensive Cancer Center — Mon, 13 May 2024 13:05:31 EST

PRMT5-mediated arginine methylation of FXR1 is essential for RNA binding in cancer cells

University of New Mexico Comprehensive Cancer Center — Fri, 10 May 2024 19:05:58 EST

Lifestyle interventions with dietary strategies after breast cancer diagnosis: a systematic review

University of New Mexico Comprehensive Cancer Center — Fri, 10 May 2024 19:05:54 EST